But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response
A group of advisers to the Food and Drug Administration voted in favor of allowing pharmacies to compound peptides like BPC-157 and TB-500, which means the hot-button peptides may soon become more broadly available to Americans
Before using glutathione, especially if you have a medical condition, are pregnant or breastfeeding, or are taking other medications, consult with a healthcare professional
Barraclough D, Obenland D, Laing W, Carroll T
Athletes bear strict liability for what enters their bodies
